Table 2. Crude and Adjusted Rate Ratios for Glaucoma Surgery and Number of Intravitreous Bevacizumab Injections per Year.
| Injections per Year, No. (%) | Cases (n = 74)a |
Controls (n = 740)b |
Rate Ratio (95% CI) | |
|---|---|---|---|---|
| Crude | Adjustedc | |||
| ≤3 | 18 (24.3) | 255 (34.5) | 1 [Reference] | 1 [Reference] |
| 4-6 | 23 (31.1) | 231 (31.2) | 1.42 | 1.65 (0.84-3.23) |
| ≥7 | 33 (44.6) | 254 (34.3) | 2.02 | 2.48 (1.25-4.93) |
a
Cases were defined as individuals identified by glaucoma surgery.
b
Controls were matched for age, preexisting glaucoma, cohort entry date, and duration of follow-up.
c
Rate ratios were adjusted for the variables in Table 1.